CLN3 and breast carcinoma: To address the extent to which CLN3 could be a prognostic factor in breast cancer, the correlation between CLN3 expression and clinical disease outcomes, such as survival, recurrence, and metastasis, in different subtypes of breast cancer, would still need to be assessed.